<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Retrovirology</journal-id><journal-title>Retrovirology</journal-title><issn pub-type="epub">1742-4690</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">15743525</article-id><article-id pub-id-type="pmc">PMC555586</article-id><article-id pub-id-type="publisher-id">1742-4690-2-15</article-id><article-id pub-id-type="doi">10.1186/1742-4690-2-15</article-id><article-categories><subj-group subj-group-type="heading"><subject>Commentary</subject></subj-group></article-categories><title-group><article-title><italic>Retrovirology </italic>highlights a quarter century of HTLV-I research</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Jeang</surname><given-names>Kuan-Teh</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>kj7e@nih.gov</email></contrib></contrib-group><aff id="I1"><label>1</label>Laboratory of Molecular Microbiology, NIAID, NIH Bethesda, Maryland 20892, USA</aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>2</day><month>3</month><year>2005</year></pub-date><volume>2</volume><fpage>15</fpage><lpage>15</lpage><ext-link ext-link-type="uri" xlink:href="http://www.retrovirology.com/content/2/1/15"/><history><date date-type="received"><day>23</day><month>2</month><year>2005</year></date><date date-type="accepted"><day>2</day><month>3</month><year>2005</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2005 Jeang; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2005</copyright-year><copyright-holder>Jeang; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Jeang
               Kuan-Teh
               
               kj7e@nih.gov
            </dc:author><dc:title>
            Retrovirology highlights a quarter century of HTLV-I research
         </dc:title><dc:date>2005</dc:date><dcterms:bibliographicCitation>Retrovirology 2(1): 15-. (2005)</dcterms:bibliographicCitation><dc:identifier type="sici">1742-4690(2005)2:1&#x0003c;15&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1742-4690</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><p>In 1977, Takatsuki and co-workers described in Japan a human malignant disease termed adult T-cell leukemia (ATL). Three years later, in 1980, Gallo and colleagues reported the identification of the first human retrovirus, human T-cell leukemia virus type I (HTLV-I), in a patient with cutaneous T-cell lymphoma. This month, <italic>Retrovirology </italic>commemorates these two land mark findings by publishing separate personal recollections by Takatsuki and Gallo respectively on the discovery of ATL and HTLV.</p></abstract></article-meta></front><body><p><italic>Retrovirology </italic>as a medical study first emerged in the early 1900s. In 1908, Ellermann and Bang reported on the transmissibility of avian leucosis by cell-free filtrates, suggesting the involvement of a virus [<xref ref-type="bibr" rid="B1">1</xref>]. Shortly afterward, in 1910, Rous demonstrated that chicken sarcomas were infectious and when inoculated into healthy birds induced tumors [<xref ref-type="bibr" rid="B2">2</xref>]. Today, a plethora of oncogenic animal retroviruses including bovine leukemia virus, feline leukemia virus, gibbon ape leukemia virus, Jaagsiektse sheep retrovirus, murine leukemia virus, mouse mammary tumor virus, reticuloendotheliosis virus, simian T-cell lymphotropic virus, and Walleye dermal sarcoma virus has been described.</p><p>Understanding how retroviruses cause cancer took a major step forward with the development of the cellular oncogene hypothesis in 1976. Thus Varmus, Bishop and colleagues [<xref ref-type="bibr" rid="B3">3</xref>] demonstrated that the viral oncogenes (<italic>v-onc</italic>) encoded by many retroviruses were captured originally from cellular sequences (i.e. <italic>c-onc</italic>). To date, three general models of retroviral transformation are accepted: a) over-expression of <italic>v-onc</italic>; b) <italic>cis</italic>-oncogenic effect from promoter insertion; and c) <italic>cis</italic>-oncogenic effect from enhancer insertion (Fig. <xref ref-type="fig" rid="F1">1A, B, C</xref>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Panels A, B, and C show the three accepted ways by which a retrovirus may transform cells: capture of a <italic>c-onc </italic>and over-expression of <italic>v-onc </italic>by the provirus (A); promoter insertion upstream of a growth controlling cellular gene (B); and enhancer insertions either upstream or downstream of growth controlling cellular genes (C). Panel D shows the stepwise ways in which HTLV-I Tax oncoprotein may transform cells by i) inactivating checkpoints to induce tolerance of damaged DNA, and ii) permitting the accumulation of unrepaired DNA lesions which ultimately convert a normal cell to a transformed cell.</p></caption><graphic xlink:href="1742-4690-2-15-1"/></fig><p>Although not yet fully understood, HTLV-I is believed to transform human T-cells neither through the acquisition of a <italic>c-onc </italic>nor by <italic>cis</italic>-insertion effects on the cellular genome. Pioneering molecular biology studies by Mitsuaki Yoshida and colleagues led to the delineation of the HTLV-I transforming gene, <italic>Tax </italic>[<xref ref-type="bibr" rid="B4">4</xref>]. Tax has no cellular homologue; and it works in <italic>trans </italic>to disrupt cellular checkpoints and destabilize genome integrity [<xref ref-type="bibr" rid="B5">5</xref>] leading to transformation (Fig. <xref ref-type="fig" rid="F1">1D</xref>). A more extensive discussion of the molecular biology of HTLV-I and its transforming function will be in an upcoming comprehensive review by Masao Matsuoka to be published in <italic>Retrovirology</italic>.</p><p>Two articles in this month's Retrovirology describe respectively the discovery of adult T-cell leukemia [<xref ref-type="bibr" rid="B6">6</xref>] and HTLV-I [<xref ref-type="bibr" rid="B7">7</xref>].</p></body><back><ack><sec><title>Acknowledgements</title><p>I thank Anthony Elmo for help with preparation of manuscript.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ellerman</surname><given-names>V</given-names></name><name><surname>Bang</surname><given-names>O</given-names></name></person-group><article-title>Experimentelle Leuk&#x000e4;mie bei H&#x000fc;hnern</article-title><source>Zentralbl Bakteriol Parasitenkd Infectionskr Hyg Abt Orig</source><year>1908</year><volume>46</volume><fpage>595</fpage></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rous</surname><given-names>P</given-names></name></person-group><article-title>A transmissible avian neoplasm. (Sarcoma of the common foul)</article-title><source>J Exp Med</source><year>1910</year><volume>12</volume><fpage>696</fpage><pub-id pub-id-type="doi">10.1084/jem.12.5.696</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stehelin</surname><given-names>D</given-names></name><name><surname>Varmus</surname><given-names>H</given-names></name><name><surname>Bishop</surname><given-names>JM</given-names></name><name><surname>Vogt</surname><given-names>PK</given-names></name></person-group><article-title>DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA</article-title><source>Nature</source><year>1976</year><volume>260</volume><fpage>170</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">176594</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>M</given-names></name></person-group><article-title>Multiple viral strategies of HTLV-1 for dysregulation of cell growth control</article-title><source>Annu Rev Immunol</source><year>2001</year><volume>19</volume><fpage>475</fpage><lpage>496</lpage><pub-id pub-id-type="pmid">11244044</pub-id><pub-id pub-id-type="doi">10.1146/annurev.immunol.19.1.475</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeang</surname><given-names>KT</given-names></name><name><surname>Giam</surname><given-names>CZ</given-names></name><name><surname>Majone</surname><given-names>F</given-names></name><name><surname>Aboud</surname><given-names>M</given-names></name></person-group><article-title>Life, death, and Tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>31991</fpage><lpage>31994</lpage><pub-id pub-id-type="pmid">15090550</pub-id><pub-id pub-id-type="doi">10.1074/jbc.R400009200</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takatsuki</surname><given-names>K</given-names></name></person-group><article-title>Discovery of adult T-cell leukemia</article-title><source>Retrovirology</source><year>2005</year><volume>2</volume><fpage>16</fpage><pub-id pub-id-type="pmid">15743528</pub-id><pub-id pub-id-type="doi">10.1186/1742-4690-2-16</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallo</surname><given-names>RC</given-names></name></person-group><article-title>The discovery of the first human retrovirus: HTLV-1 and HTLV-2</article-title><source>Retrovirology</source><year>2005</year><volume>2</volume><fpage>17</fpage><pub-id pub-id-type="pmid">15743526</pub-id><pub-id pub-id-type="doi">10.1186/1742-4690-2-17</pub-id></citation></ref></ref-list></back></article>



